Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients

Condition:   COVID-19 Interventions:   Biological: allogeneic human dental pulp stem cells (BSH BTC& Utooth BTC);   Other: Intravenous saline injection (Placebo) Sponsors:   Renmin Hospital of Wuhan University;   Beijing SH Bio-Tech Corporation, Beijing (CN);   Utooth Biological Technology Co., Ltd. Hubei (CN) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials